Aberrant NLRP3 inflammasome activation contributes to diverse inflammatory disorders, including sepsis, CAPS, peritonitis, atherosclerosis, and experimental autoimmune encephalomyelitis (EAE), underscoring its therapeutic relevance. This evidence concerns the gene NLRP3 and peritonitis.